Earnings ·
InfuSystem Holdings reported second quarter 2026 net revenues of $36.9 million, a 2.6% increase year-over-year, driven…
INFUInfuSystem Holdings, Inc
InfuSystem Holdings reported second quarter 2026 net revenues of $36.9 million, a 2.6% increase year-over-year, driven by a 15.2% rise in Patient Services revenue to $24.8 million, partially offset by a 16.1% decline in Device Solutions revenue due to a GE Healthcare contract restructuring. Net income rose to $3.2 million ($0.15 diluted EPS) from $2.6 million ($0.12 diluted EPS), with Adjusted EBITDA increasing 7.6% to $8.6 million and margin expanding to 23.4%. The company reaffirmed full-year 2026 pro-forma revenue growth guidance of 6% to 8% and mid-to-low 20s Adjusted EBITDA margins, while noting $55.2 million in total liquidity as of June 30, 2026. InfuSystem Holdings operates in the healthcare services industry, providing durable medical equipment and outpatient care solutions.